Health
Eli Lilly Acquires Centessa in $7.8 Billion Sleep Disorder Deal
Eli Lilly expands its neurology pipeline with a major acquisition of UK-based Centessa Pharmaceuticals, targeting treatments for excessive daytime sleepiness.